Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05UIL
|
||||
| Former ID |
DCL001027
|
||||
| Drug Name |
TV-4710
|
||||
| Indication | Systemic lupus erythematosus [ICD9: 710; ICD10:M32] | Discontinued in Phase 2 | [1] | ||
| Company |
Teva
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C111H149N27O28
|
||||
| Target and Pathway | |||||
| Target(s) | DNA | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | Emergence of targeted immune therapies for systemic lupus. Expert Opin Emerg Drugs. 2005 Feb;10(1):53-65. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.